Modulating factors of fibromyalgia in women during the COVID-19 pandemic: A protocol for systematic review

Medicine (Baltimore). 2022 Dec 30;101(52):e32577. doi: 10.1097/MD.0000000000032577.

Abstract

Background: Fibromyalgia is a disease that affects mostly women and is related to stressors. The aim of this study was to assess how the Coronavirus disease 2019 pandemic has affected women with fibromyalgia.

Methods: A systematic review was conducted in the PubMed, ScienceDirect, and Springer Link databases, following the recommendations of the preferred reporting items for systematic reviews and meta-analyses statement. The methodological quality was assessed using the Joanna Briggs Institute critical appraisal tools for non-randomized studies.

Results: A total of 6 studies were included. Most results indicated a worsening in the mental health of women with fibromyalgia during the pandemic, and this in turn impacted on physical health.

Conclusion: The mental health of women with fibromyalgia was more affected during the Coronavirus disease 2019 pandemic period than that of non-fibromyalgia sufferers. This was also reflected in the worsening of symptoms and weakness in performing daily activities.

MeSH terms

  • COVID-19* / epidemiology
  • Female
  • Humans
  • Male
  • Mental Health
  • Pandemics
  • Research Design
  • Systematic Reviews as Topic